Literature DB >> 10668954

Tuberculosis in chronic renal failure in Jeddah.

S Al Shohaib1.   

Abstract

The incidence of tuberculosis is still high in many developing countries and immunocompromised patients with chronic renal failure requiring haemodialysis have been reported to be at increased risk of developing tuberculosis. In this study 80 patients with chronic renal failure were followed up for a period of three years and were carefully monitored for the development of tuberculosis. Mantoux test, chest radiograph and sputum were performed at the beginning of the study and every six months thereafter. At the end of the study period, 8 (10%) of the patients had developed tuberculosis, confirming the high incidence of tuberculosis in this group of patients. No particular underlying renal disease was associated with the development of tuberculosis. Four patients developed pulmonary tuberculosis, 2 renal tuberculosis and one each with cervical tuberculous lymphadenitis and tuberculous meningitis. All patients responded satisfactorily to anti-tuberculosis therapy as diagnosis was established early. The delayed recognition of tuberculosis and therefore a delay in the initiation of effective treatment is not only detrimental to the patient but also results in a potentially profound impact on public health. We recommend routine screening for tuberculosis in patients with chronic renal failure presenting at Renal Units and tuberculosis chemoprophylaxis for those undergoing haemodialysis, particularly in countries with high incidence of tuberculosis.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10668954     DOI: 10.1023/a:1007187900652

Source DB:  PubMed          Journal:  Int Urol Nephrol        ISSN: 0301-1623            Impact factor:   2.370


  9 in total

1.  The present status of active tuberculosis in a general hospital; a study of 186 cases.

Authors:  H Yamada; O Katoh; K Hiura; Y Nakanishi; S Kuroki; Y Aoki; Y Nakahara; M Yamaguchi
Journal:  Jpn J Med       Date:  1991 Jul-Aug

2.  Nationwide community survey of tuberculosis epidemiology in Saudi Arabia.

Authors:  F A al-Kassimi; A K Abdullah; M S al-Hajjaj; I O al-Orainey; E A Bamgboye; M N Chowdhury
Journal:  Tuber Lung Dis       Date:  1993-08

3.  Successful therapy of tuberculosis in hemodialysis patients.

Authors:  M al-Homrany
Journal:  Am J Nephrol       Date:  1997       Impact factor: 3.754

Review 4.  A 1990s perspective of hepatitis C, human immunodeficiency virus, and tuberculosis infections in dialysis patients.

Authors:  B V Murthy; B J Pereira
Journal:  Semin Nephrol       Date:  1997-07       Impact factor: 5.299

5.  Observations in a Saudi-Arabian dialysis population over a 13-year period.

Authors:  M M Hussein; J M Mooij; H Roujouleh; H el-Sayed
Journal:  Nephrol Dial Transplant       Date:  1994       Impact factor: 5.992

6.  The benefits of isoniazid chemoprophylaxis and risk factors for tuberculosis among Oglala Sioux Indians.

Authors:  M A Mori; G Leonardson; T K Welty
Journal:  Arch Intern Med       Date:  1992-03

7.  Tuberculosis in patients on maintenance dialysis.

Authors:  A Mitwalli
Journal:  Am J Kidney Dis       Date:  1991-11       Impact factor: 8.860

8.  Increased incidence of tuberculosis in patients undergoing hemodialysis.

Authors:  K Cengiz
Journal:  Nephron       Date:  1996       Impact factor: 2.847

9.  Pulmonary tuberculosis in Saudi Arabia: A retrospective study of 1566 patients.

Authors:  M S Al-Hajjaj; L Pandya; A A Marie; A A Madani; N Al-Sharif; S Al-Majed
Journal:  Ann Saudi Med       Date:  1991-07       Impact factor: 1.526

  9 in total
  2 in total

1.  A Case Report of Renal Tuberculosis With Associated Unusual Pulmonary Findings.

Authors:  Abdullah Almazloum; Tasnim Elgazzar; Maha Alkhayat; Lina A Alansari; Sami Almustanyir
Journal:  Cureus       Date:  2021-11-28

2.  Chronic kidney disease correlates with increased risk of pulmonary tuberculosis before initiating renal replacement therapy: A cohort study in Taiwan.

Authors:  Kao-Chi Cheng; Kuan-Fu Liao; Cheng-Li Lin; Chiu-Shong Liu; Shih-Wei Lai
Journal:  Medicine (Baltimore)       Date:  2018-09       Impact factor: 1.889

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.